logo

For the Inventor, By the Inventor

Cambridge, MA, United States of America

Ariad Gene Therapeutics, Inc.

Calculating rank
USPTO Granted Patents = 13

Forward Citations = 336

Loading Chart...
Loading Chart...

20 inventors (with patents filed for the assignee):

goldMedal Leonard W Rozamus (6 out of 23 patents)

silverMedal Michael Z Gilman (6 out of 8 patents)

bronzeMedal Dennis Alan Holt (6 out of 35 patents)

4.  Wu Yang (5 out of 48 patents)

5.  Timothy P Clackson (4 out of 6 patents)

6.  Terence P Keenan (3 out of 23 patents)

7.  Sridaran Natesan (3 out of 4 patents)

8.  Yihan Wang (2 out of 36 patents)

9.  David L Berstein (2 out of 6 patents)

10.  Cheryl A Digits (2 out of 2 patents)

11.  Tao Guo (1 out of 48 patents)

12.  James Edward Rothman (1 out of 19 patents)

13.  Victor M Rivera (1 out of 2 patents)

14.  Chester A Metcalf, Iii (1 out of 34 patents)

15.  Edgardo Laborde (1 out of 14 patents)


13 patents:

1. 7196192 - 28-epirapalogs (2007-03-27),
2. 7186826 - Phosphorus-containing compounds and uses thereof (2007-03-06),
3. 7091213 - Phosphorus-containing compounds and uses thereof (2006-08-15),
4. 7067526 - 28-epirapalogs (2006-06-27),
5. 6693189 - Materials and method for treating or preventing pathogenic fungal infection (2004-02-17),
6. 6649595 - Regulation of biological events using novel compounds (2003-11-18),
7. 6566073 - Materials and methods involving conditional retention domains (2003-05-20),
8. 6509152 - Immunosuppressant target proteins (2003-01-21),
9. 6506379 - Intramuscular delivery of recombinant AAV (2003-01-14),
10. 6479653 - Compositions and method for regulation of transcription (2002-11-12),
11. 6306649 - Heterologous transcription factors (2001-10-23),
12. 6133456 - Synthetic multimerizing agents (2000-10-17),
13. 6117680 - Compositions and methods for regulation of transcription (2000-09-12),
Company Overview
Ariad Gene Therapeutics, Inc. is a biotechnology company based in Cambridge, MA, specializing in the development of innovative gene therapies. The organization focuses on harnessing advanced genetic engineering techniques to address a range of genetic disorders and diseases. By leveraging cutting-edge research in gene editing and delivery systems, Ariad aims to create transformative treatments that improve patient outcomes and advance the field of precision medicine. Its commitment to scientific excellence positions it as a key player in the evolving landscape of gene therapy.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

13 Patents

#193 in Cambridge, MA

#1,443 in Massachusetts

#23,854 in US

#45,081 in the World

Cambridge, MA (US)
Cambridge, MA, United States of America

Ariad Gene Therapeutics, Inc.

Forward Citations = 336

20 inventors:

goldMedal Leonard W Rozamus (6 out of 23 patents)

silverMedal Michael Z Gilman (6 out of 8 patents)

bronzeMedal Dennis Alan Holt (6 out of 35 patents)

4.  Wu Yang (5 out of 48 patents)

5.  Timothy P Clackson (4 out of 6 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Ariad Gene Therapeutics, Inc.. Retrieved from https://idiyas.com/company/ariad-gene-therapeutics

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…